Navigation Links
Vical Biotech and NIH jointly develops HIV vaccine

A new HIV vaccine is being jointly developed by Vical Pharmaceuticals and the National Institute of Health (NIH). The new HIV vaccine was developed by the scientistis in NIH and the Federal government is using the Vical Biotechs DNA delivery technology to inserting the HIV genes//.

Vical Inc. is a Biotechnology company based in California, which has developed an accurate DNA delivery system, last month Vical has agreed to grant Merck to use its gene delivery system technology for cancer vaccines in exchange for rights to use the technology for vaccines against HIV. The Phase 2 clinical trial is performed by HIV vaccine trial group of NIH, this technology incorporates 4 HIV genes and the NIH trial group evaluates and compares different HIV/AIDS vaccines.

The news sent shares of Vical up $1.16, or 21.60 percent, to $6.54 in morning trade on Nasdaq, after touching high of $6.98. The stock was among the biggest percentage gainers on Nasdaq.

Source: Reuters.
'"/>




Page: 1

Related medicine news :

1. Biotechnology industry expected to grow into a three billion dollar industry by 2002
2. Biotechnology on the lead
3. Panacea Biotech To Market Anthrax Vaccine
4. Commercialization of Biotech Discoveries, An Encouragement For Researchers
5. Biotech drug causing anemia-EPREX
6. Leading Biotech Companies Are Interested In Acquisition Of Smaller Companies
7. Biologicals Transfer Proposal between US and Indian Biotechnology
8. Biotechnology Initiatives Planned In Hyderabad
9. Biotech Osiris to go public
10. Western Region Tops in Indian Biotech Growth
11. Pediatric Dengue Vaccine Initiative and Hawaii Biotech Partner Against Dengue Fever
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... , ... February 12, 2016 ... ... today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to develop the advanced ... will recruit top students from U.S. universities who will draw from Siemens’ ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections Meeting. ... Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues. As in years past, HydroWorx is proud ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare ... San Francisco General Hospital on April 5-7. The series is a multi-day, multi-workshop ... habits. The workshops cover a broad range of topics, including coaching skills, the ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young Asset ... celebrates the beginning of the latest charity campaign in their community enrichment program. ... Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ . ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... LOUISVILLE, Ky. , Feb. 12, 2016 ... it has completed a $47.1 million Series ... investors Cormorant Asset Management, Hillhouse Capital Group ... investors Morningside Venture Investments, AJU IB Investment, ... will be used to further advance clinical ...
(Date:2/11/2016)... , Feb. 11, 2016 Stem cells are ... characterized by self-renewal and the capacity to differentiate into ... new discovery, as the first mouse embryonic stem cells ... not until 1995 that the first culturing of embryonic ... cells were not produced until 2006 As a result ...
(Date:2/11/2016)... , Feb. 11, 2016  Governor Andrew M. Cuomo ... create 1,400 jobs throughout Western New York ... with the SUNY Polytechnic Institute, includes a major expansion ... in Buffalo , as well as ... facility in Dunkirk . The combined ...
Breaking Medicine Technology: